These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

337 related articles for article (PubMed ID: 22305837)

  • 21. Relation between infarct size in ST-segment elevation myocardial infarction treated successfully by percutaneous coronary intervention and left ventricular ejection fraction three months after the infarct.
    Pride YB; Giuseffi JL; Mohanavelu S; Harrigan CJ; Manning WJ; Gibson CM; Appelbaum E
    Am J Cardiol; 2010 Sep; 106(5):635-40. PubMed ID: 20723637
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Randomized evaluation of the effects of filter-based distal protection on myocardial perfusion and infarct size after primary percutaneous catheter intervention in myocardial infarction with and without ST-segment elevation.
    Gick M; Jander N; Bestehorn HP; Kienzle RP; Ferenc M; Werner K; Comberg T; Peitz K; Zohlnhöfer D; Bassignana V; Buettner HJ; Neumann FJ
    Circulation; 2005 Sep; 112(10):1462-9. PubMed ID: 16129793
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Thrombus aspiration plus intra-infarct-related artery administration of tirofiban improves myocardial perfusion during primary angioplasty for acute myocardial infarction.
    Yan HB; Li SY; Song L; Wang J; Wu Z; Chi YP; Zheng B; Zhao HJ; Li QX; Zhang XJ; Li WZ
    Chin Med J (Engl); 2010 Apr; 123(7):877-83. PubMed ID: 20497681
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effect of Erythropoietin in patients with acute myocardial infarction: five-year results of the REVIVAL-3 trial.
    Steppich B; Groha P; Ibrahim T; Schunkert H; Laugwitz KL; Hadamitzky M; Kastrati A; Ott I;
    BMC Cardiovasc Disord; 2017 Jan; 17(1):38. PubMed ID: 28109258
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effects of primary angioplasty for acute myocardial infarction on early and late infarct size and left ventricular wall characteristics.
    Baks T; van Geuns RJ; Biagini E; Wielopolski P; Mollet NR; Cademartiri F; van der Giessen WJ; Krestin GP; Serruys PW; Duncker DJ; de Feyter PJ
    J Am Coll Cardiol; 2006 Jan; 47(1):40-4. PubMed ID: 16386662
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Intracoronary administration of darbepoetin-alpha at onset of reperfusion in acute myocardial infarction: results of the randomized Intra-Co-EpoMI trial.
    Roubille F; Micheau A; Combes S; Thibaut S; Souteyrand G; Cayla G; Bonello L; Lesavre N; Sportouch-Dukhan C; Klein F; Berboucha S; Cade S; Cung TT; Raczka F; Macia JC; Gervasoni R; Cransac F; Leclercq F; Barrère-Lemaire S; Paganelli F; Mottref P; Vernhet Kovacsik H; Ovize M; Piot C
    Arch Cardiovasc Dis; 2013 Mar; 106(3):135-45. PubMed ID: 23582675
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A single dose of erythropoietin in ST-elevation myocardial infarction.
    Voors AA; Belonje AM; Zijlstra F; Hillege HL; Anker SD; Slart RH; Tio RA; van 't Hof A; Jukema JW; Peels HO; Henriques JP; Ten Berg JM; Vos J; van Gilst WH; van Veldhuisen DJ;
    Eur Heart J; 2010 Nov; 31(21):2593-600. PubMed ID: 20802250
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Clinical benefits of adjunctive tirofiban therapy in patients with acute ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention.
    Shen J; Zhang Q; Zhang RY; Zhang JS; Hu J; Yang ZK; Zheng AF; Zhang X; Shen WF
    Coron Artery Dis; 2008 Jun; 19(4):271-7. PubMed ID: 18480672
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Influence of ST-segment recovery on infarct size and ejection fraction in patients with ST-segment elevation myocardial infarction receiving primary percutaneous coronary intervention.
    Hallén J; Sejersten M; Johanson P; Atar D; Clemmensen PM
    Am J Cardiol; 2010 May; 105(9):1223-8. PubMed ID: 20403470
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Intracoronary ECG during primary percutaneous coronary intervention for ST-segment elevation myocardial infarction predicts microvascular obstruction and infarct size.
    Wong DT; Leung MC; Das R; Liew GY; Teo KS; Chew DP; Meredith IT; Worthley MI; Worthley SG
    Int J Cardiol; 2013 Apr; 165(1):61-6. PubMed ID: 21875755
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effects of atorvastatin pretreatment on infarct size in patients with ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention.
    Hahn JY; Kim HJ; Choi YJ; Jo SH; Kim HJ; Lee S; Ahn KJ; Song YB; Choi JH; Choi SH; Choi YJ; Lee KH; Lee SH; Gwon HC
    Am Heart J; 2011 Dec; 162(6):1026-33. PubMed ID: 22137076
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The relationships between cardiovascular magnetic resonance imaging variables of acute myocardial infarction and both left ventricular dysfunction and immediate postreperfusion ST segment recovery.
    Bekkers SC; Lemmert ME; Passos VL; Mihl C; Schalla S; Wildberger JE; Waltenberger J; Gorgels AP
    J Electrocardiol; 2011; 44(5):561-7. PubMed ID: 21872003
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Stem cell mobilization induced by subcutaneous granulocyte-colony stimulating factor to improve cardiac regeneration after acute ST-elevation myocardial infarction: result of the double-blind, randomized, placebo-controlled stem cells in myocardial infarction (STEMMI) trial.
    Ripa RS; Jørgensen E; Wang Y; Thune JJ; Nilsson JC; Søndergaard L; Johnsen HE; Køber L; Grande P; Kastrup J
    Circulation; 2006 Apr; 113(16):1983-92. PubMed ID: 16531621
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Early electrocardiographic findings and MR imaging-verified microvascular injury and myocardial infarct size.
    Nijveldt R; van der Vleuten PA; Hirsch A; Beek AM; Tio RA; Tijssen JG; Piek JJ; van Rossum AC; Zijlstra F
    JACC Cardiovasc Imaging; 2009 Oct; 2(10):1187-94. PubMed ID: 19833308
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Intracoronary nitroprusside for the prevention of the no-reflow phenomenon after primary percutaneous coronary intervention in acute myocardial infarction. A randomized, double-blind, placebo-controlled clinical trial.
    Amit G; Cafri C; Yaroslavtsev S; Fuchs S; Paltiel O; Abu-Ful A; Weinstein JM; Wolak A; Ilia R; Zahger D
    Am Heart J; 2006 Nov; 152(5):887.e9-14. PubMed ID: 17070151
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effects of balloon-based distal protection during primary percutaneous coronary intervention on early and late infarct size and left ventricular remodeling: a pilot study using serial contrast-enhanced magnetic resonance imaging.
    Hahn JY; Gwon HC; Choe YH; Rhee I; Choi SH; Choi JH; Lee SH; Hong KP; Park JE
    Am Heart J; 2007 Apr; 153(4):665.e1-8. PubMed ID: 17383309
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Characterization of microvascular dysfunction after acute myocardial infarction by cardiovascular magnetic resonance first-pass perfusion and late gadolinium enhancement imaging.
    Yan AT; Gibson CM; Larose E; Anavekar NS; Tsang S; Solomon SD; Reynolds G; Kwong RY
    J Cardiovasc Magn Reson; 2006; 8(6):831-7. PubMed ID: 17060106
    [TBL] [Abstract][Full Text] [Related]  

  • 38. ST-segment resolution assessed immediately after primary percutaneous coronary intervention correlates with infarct size and left ventricular function in cardiac magnetic resonance at 1-year follow-up.
    Rakowski T; Dziewierz A; Siudak Z; Mielecki W; Brzozowska-Czarnek A; Legutko J; Rzeszutko L; Urbanik A; Dubiel JS; Dudek D
    J Electrocardiol; 2009; 42(2):152-6. PubMed ID: 19167012
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effect of erythropoietin as an adjunct to primary percutaneous coronary intervention: a randomised controlled clinical trial.
    Ludman AJ; Yellon DM; Hasleton J; Ariti C; Babu GG; Boston-Griffiths E; Venugopal V; Walker M; Holdright D; Swanton H; Crake T; Brull D; Moon JC; Puranik R; Muthurangu V; Taylor A; Hausenloy DJ
    Heart; 2011 Oct; 97(19):1560-5. PubMed ID: 21900585
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The effect of intravenous administration of erythropoietin on the infarct size in primary percutaneous coronary intervention.
    Suh JW; Chung WY; Kim YS; Kim KI; Jeon EJ; Cho YS; Youn TJ; Chae IH; Kim CH; Choi DJ
    Int J Cardiol; 2011 Jun; 149(2):216-220. PubMed ID: 20199815
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.